CIK 0000920148
- Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 992588107
- Phone
- +1 336-229-1127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,377,699
- in 4 filings, $108K under 10b5-1 plans
Net −$1,377,699. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-07 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Shares withheld for taxes | −171 | $223.71 | $38K | 20,972.04 |
| 2024-02-07 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Exercise or conversion | +112 | 21,084.04 | ||
| 2024-02-07 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Shares withheld for taxes | −33 | $223.71 | $7K | 21,051.04 |
| 2024-02-07 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Exercise or conversion · Restricted Stock Unit | −517 | 15,880 | ||
| 2024-02-07 | Caveney Brian J EVP, Pres of ED, CMO & CSO | Exercise or conversion · Restricted Stock Unit | −112 | 15,768 | ||
| 2024-02-07 | BERBERIAN LANCE EVP, CIO & CTO | Exercise or conversion | +353 | 23,473 | ||
| 2024-02-07 | BERBERIAN LANCE EVP, CIO & CTO | Shares withheld for taxes | −94 | $223.71 | $21K | 23,379 |
| 2024-02-07 | BERBERIAN LANCE EVP, CIO & CTO | Exercise or conversion · Restricted Stock Unit | −353 | 10,121 | ||
| 2024-02-07 | Bailey Megan D. EVP, Chief Strategy Officer | Exercise or conversion | +224 | 346 | ||
| 2024-02-07 | Bailey Megan D. EVP, Chief Strategy Officer | Shares withheld for taxes | −87 | $223.71 | $19K | 259 |
| 2024-02-07 | Bailey Megan D. EVP, Chief Strategy Officer | Exercise or conversion | +67 | 326 | ||
| 2024-02-07 | Bailey Megan D. EVP, Chief Strategy Officer | Shares withheld for taxes | −26 | $223.71 | $6K | 300 |
| 2024-02-07 | Bailey Megan D. EVP, Chief Strategy Officer | Exercise or conversion · Restricted Stock Unit | −224 | 5,679 | ||
| 2024-02-07 | Bailey Megan D. EVP, Chief Strategy Officer | Exercise or conversion · Restricted Stock Unit | −67 | 5,612 | ||
| 2024-02-07 | GRAHAM ANITA Z EVP, CHRO | Exercise or conversion | +369 | 399 | ||
| 2024-02-07 | GRAHAM ANITA Z EVP, CHRO | Shares withheld for taxes | −107 | $223.71 | $24K | 292 |
| 2024-02-07 | GRAHAM ANITA Z EVP, CHRO | Exercise or conversion · Restricted Stock Unit | −369 | 1,716 | ||
| 2024-02-07 | Schroeder Mark S EVP, Pres Diagnostics & COO | Exercise or conversion | +517 | 7,638.14 | ||
| 2024-02-07 | Schroeder Mark S EVP, Pres Diagnostics & COO | Shares withheld for taxes | −138 | $223.71 | $31K | 7,500.14 |
| 2024-02-07 | Schroeder Mark S EVP, Pres Diagnostics & COO | Exercise or conversion | +163 | 7,663.14 |
Page 30 of 41 · 816 trades